February 12th, 2018 – Toronto, Ontario – Matica Enterprises Inc. (MMJ – CSE) (39N – Frankfurt) (MQPXF – OTC) (“Matica” or the “Company”) is pleased to provide the following update regarding the issue of common shares by Matica. Our next release of financials, audited for the twelve months ended December 31, 2017, are not due to be filed until April 20, 2018. The Company has therefore chosen to disclose the number of stock options, warrants, and broker warrants exercised and the corresponding amount of dollar inflows as management has deemed these to be significant information for the shareholders and the investing public.
For the quarter ended December 31, 2017, Matica has issued 33,699,500 common shares with proceeds of $3,879,225 as follows:
-14,300,000 common shares for the exercise of stock options with proceeds of $1,612,500
-12,560,000 common shares for the exercise of warrants at $0.10 with proceeds of $1,256,000
– 6,687,500 common shares for the exercise of warrants at $0.15 with proceeds of $1,003,125
– 152,000 common shares for the exercise of broker warrants at $0.05 with proceeds of $7,600
The above have resulted in the Company having 262,807,191 common shares outstanding at December 31, 2017.
In addition to the above, for the month ended January 31, 2018, Matica has issued 15,779,667 common shares with proceeds of $3,466,710 as follows:
-6,300,000 common shares for the exercise of stock options with proceeds of $2,446,000
-7,430,000 common shares for the exercise of warrants at $0.10 with proceeds of $743,000
-1,752,275 common shares for the exercise of warrants at $0.15 with proceeds of $262,841
– 297,392 common shares for the exercise of broker warrants at $0.05 with proceeds of $14,869
Mr. George A. Brown, Director and Interim CFO states: ‘We feel that it is important for our shareholders to know that Matica is in a very strong financial position to complete our Dorval facility through to submission to Health Canada for a cultivation licence and subsequent submission for a licence to sell under the ACMPR program. The Company continues to pursue other business opportunities in the medical marijuana sector including an ongoing search for a suitable location for an expansion facility.”
For more information on Matica Enterprises please visit the website at: www.westislandbrands.com.
On behalf of the Board of Directors
MATICA ENTERPRISES INC.
George A. Brown
George A. Brown, Interim CFO
The Company’s filings are available for review at www.sedar.com and www.thecse.com.
For further information, please contact Boris Ziger, Chief Executive Officer, at:
Telephone: 416-304-9935
E-mail: info@westislandbrands.com
Website: www.westislandbrands.com
Disclaimer for Forward-Looking Information
This news release contains statements about the Company’s information that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.